Rola F. Jaafar

Suggest Changes
Learn More
PURPOSE To demonstrate the efficacy of intravitreal bevacizumab for treatment of neovascular age-related macular degeneration (AMD). DESIGN Prospective, open-label, nonrandomized clinical study. (More)
  • 1